Common disease signatures from gene expression analysis in Huntington’s disease human blood and brain - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Orphanet Journal of Rare Diseases Year : 2015

Common disease signatures from gene expression analysis in Huntington’s disease human blood and brain

Eleni Mina
  • Function : Correspondent author
  • PersonId : 987054

Connectez-vous pour contacter l'auteur
Willeke van Roon-Mom
  • Function : Author
  • PersonId : 987055
Kristina Hettne
  • Function : Author
  • PersonId : 987056
Peter A.C. ’t Hoen
  • Function : Author
  • PersonId : 987300
Barend Mons
  • Function : Author
  • PersonId : 987059
Marco Roos
  • Function : Author
  • PersonId : 987060

Abstract

AbstractBackgroundHuntington’s disease (HD) is a devastating brain disorder with no effective treatment or cure available. The scarcity of brain tissue makes it hard to study changes in the brain and impossible to perform longitudinal studies. However, peripheral pathology in HD suggests that it is possible to study the disease using peripheral tissue as a monitoring tool for disease progression and/or efficacy of novel therapies. In this study, we investigated if blood can be used to monitor disease severity and progression in brain. Since previous attempts using only gene expression proved unsuccessful, we compared blood and brain Huntington’s disease signatures in a functional context.MethodsMicroarray HD gene expression profiles from three brain regions were compared to the transcriptome of HD blood generated by next generation sequencing. The comparison was performed with a combination of weighted gene co-expression network analysis and literature based functional analysis (Concept Profile Analysis). Uniquely, our comparison of blood and brain datasets was not based on (the very limited) gene overlap but on the similarity between the gene annotations in four different semantic categories: “biological process”, “cellular component”, “molecular function” and “disease or syndrome”.ResultsWe identified signatures in HD blood reflecting a broad pathophysiological spectrum, including alterations in the immune response, sphingolipid biosynthetic processes, lipid transport, cell signaling, protein modification, spliceosome, RNA splicing, vesicle transport, cell signaling and synaptic transmission. Part of this spectrum was reminiscent of the brain pathology. The HD signatures in caudate nucleus and BA4 exhibited the highest similarity with blood, irrespective of the category of semantic annotations used. BA9 exhibited an intermediate similarity, while cerebellum had the least similarity. We present two signatures that were shared between blood and brain: immune response and spinocerebellar ataxias.ConclusionsOur results demonstrate that HD blood exhibits dysregulation that is similar to brain at a functional level, but not necessarily at the level of individual genes. We report two common signatures that can be used to monitor the pathology in brain of HD patients in a non-invasive manner. Our results are an exemplar of how signals in blood data can be used to represent brain disorders. Our methodology can be used to study disease specific signatures in diseases where heterogeneous tissues are involved in the pathology.
Fichier principal
Vignette du fichier
13023_2016_Article_475.pdf (1.28 Mo) Télécharger le fichier
13023_2016_475_MOESM1_ESM.pdf (1.32 Mo) Télécharger le fichier
Origin : Publication funded by an institution
Origin : Publication funded by an institution

Dates and versions

inserm-01350634 , version 1 (01-08-2016)

Identifiers

Cite

Eleni Mina, Willeke van Roon-Mom, Kristina Hettne, Erik van Zwet, Jelle Goeman, et al.. Common disease signatures from gene expression analysis in Huntington’s disease human blood and brain. Orphanet Journal of Rare Diseases, 2015, 11 (1), pp.97. ⟨10.1186/s13023-016-0475-2⟩. ⟨inserm-01350634⟩
245 View
185 Download

Altmetric

Share

Gmail Facebook X LinkedIn More